WEIGHT LOSS DRUGS INSURANCE COVERAGE

SB 193 requires health insurers in New Mexico to cover at least one injectable weight loss drug (specifically a glucagon-like peptide-1 receptor agonist) for adults with obesity who need long-term weight management. It applies to all group health plans, individual insurance policies, HMOs, and nonprofit health care plans delivered or renewed after January 1, 2026. The law directly affects insured adults with obesity by mandating coverage for these medications and insurers who must add this coverage to their plans. It does not specify which drug must be covered, only that at least one such injectable option must be included in prescription drug coverage.